What does the evidence say about Citrus Bergamot Lipid Profile Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Citrus Bergamot Lipid Profile Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - 1 2 3 Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer []. [Pujia Carmelo (2026); evidence level 1] - Furthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system [,]. [Pujia Carmelo (2026); evidence level 1] - It is well known that a weight loss of between 5% and 10% is sufficient to achieve clinically significant improvements in health risk factors []. [Pujia Carmelo (2026); evidence level 1] - It is a major public health concern that has reached pandemic proportions worldwide. [Pujia Carmelo (2026); evidence level 1] - Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver disease worldwide, with an overall global prevalence of 30% [...]. [Rodriguez-Ramiro I (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.